NCT06037590View on ClinicalTrials.gov

A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

October 20, 2023

Study Completion Date

October 27, 2023

Conditions
ParkinsonParkinson DiseaseParkinson's Disease and Parkinsonism
Interventions
COMBINATION_PRODUCT

Levodopa Cyclops®

Orally inhaled dry powder levodopa from the Cyclops® dry powder inhaler

COMBINATION_PRODUCT

INBRIJA®

Orally inhaled dry powder levodopa from the ARCUS® dry powder inhaler

Trial Locations (1)

1202

Bed space for short term stay at Diagnostic & Consultative Centre 'Ascendent' Ltd., Sofia

All Listed Sponsors
collaborator

Cooperative Clinical Drug Research and Development AG (CCDRD AG)

OTHER

lead

PureIMS B.V.

INDUSTRY

NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA® | Biotech Hunter | Biotech Hunter